Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Mar 18, 2025

BUY
$26.13 - $33.94 $52,260 - $67,880
2,000 Added 10.0%
22,000 $633 Million
Q2 2023

Mar 18, 2025

SELL
$36.12 - $41.79 $902,999 - $1.04 Million
-25,000 Reduced 55.56%
20,000 $734 Million
Q1 2023

Mar 18, 2025

BUY
$39.39 - $51.28 $1.67 Million - $2.18 Million
42,500 Added 1700.0%
45,000 $1.84 Billion
Q3 2022

Mar 18, 2025

SELL
$43.76 - $53.42 $547,000 - $667,750
-12,500 Reduced 83.33%
2,500 $589 Million
Q2 2022

Mar 18, 2025

SELL
$46.53 - $55.17 $232,650 - $275,850
-5,000 Reduced 25.0%
15,000 $786 Million
Q3 2020

Mar 18, 2025

BUY
$31.75 - $37.25 $95,250 - $111,750
3,000 Added 17.65%
20,000 $734 Million
Q2 2020

Mar 18, 2025

BUY
$30.12 - $36.54 $512,040 - $621,180
17,000 New
17,000 $556 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Criteria Caixa, S.A.U. Portfolio

Follow Criteria Caixa, S.A.U. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criteria Caixa, S.A.U., based on Form 13F filings with the SEC.

News

Stay updated on Criteria Caixa, S.A.U. with notifications on news.